{
    "schema": 1,
    "fid": "why-india-s-glp-1-boom-could-put-fakes",
    "type": "article",
    "object_id": 840,
    "title": "Why India’s GLP-1 boom could put fakes in your vials",
    "entity": "Why India’s GLP-1 boom could put fakes in your vials",
    "url": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes",
    "facts_url": "https://www.preppinpeppers.com/facts/why-india-s-glp-1-boom-could-put-fakes",
    "currency": null,
    "tldr": "A surge in demand for GLP-1 research peptides from India is drawing unvetted manufacturers into the supply chain, raising the odds of a mislabeled or fake vial.",
    "facts": [
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:title",
            "category": "identity",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "title",
            "value": "Why India’s GLP-1 boom could put fakes in your vials",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:published",
            "category": "identity",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "published",
            "value": "2026-09-14",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:author",
            "category": "identity",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "author",
            "value": "PreppinPeppers Editorial Team",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:topics",
            "category": "identity",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "topics",
            "value": "breaking news, News, peptide news",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:summary",
            "category": "content",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "summary",
            "value": "A surge in demand for GLP-1 research peptides from India is drawing unvetted manufacturers into the supply chain, raising the odds of a mislabeled or fake vial.",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:section-1",
            "category": "content",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "section",
            "value": "What GLP-1 peptides are",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:section-2",
            "category": "content",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "section",
            "value": "What GLP-1 is",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:section-3",
            "category": "content",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "section",
            "value": "The receptor math behind semaglutide, tirzepatide, and retatrutide",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:section-4",
            "category": "content",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "section",
            "value": "What a demand boom does to the supply chain",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:section-5",
            "category": "content",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "section",
            "value": "What researchers get wrong about GLP-1 peptides",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:section-8",
            "category": "content",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "section",
            "value": "Related reading",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:source-www-news18-com",
            "category": "source",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "cites",
            "value": "this coverage at News18 → - www.news18.com",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.news18.com/lifestyle/health-and-fitness/the-glp-1-effect-how-weight-loss-drugs-are-changing-what-india-eats-buys-and-believes-about-health-10328507.html"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:source-pubmed-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "cites",
            "value": "D'Hondt et al., J Pharm Biomed Anal 2014: Related impurities in peptide medicines - pubmed.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://pubmed.ncbi.nlm.nih.gov/25044089/"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:source-pmc-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "cites",
            "value": "Thacker et al., Front Immunol 2022: Detection of innate immune response modulating impurities (IIRMI) in therapeutic peptides and proteins: Impact of excipients - pmc.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9485840/"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:source-pubmed-ncbi-nlm-nih-gov-2",
            "category": "source",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "cites",
            "value": "Badgujar et al., Chirality 2024: Enantiomeric purity of synthetic therapeutic peptides: A review - pubmed.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://pubmed.ncbi.nlm.nih.gov/38448043/"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:product-gansulin-metal-peptide-pen",
            "category": "products",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "references product",
            "value": "Gansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-metal-peptide-pen"
        },
        {
            "id": "why-india-s-glp-1-boom-could-put-fakes:product-gansulin-3ml-cartridge",
            "category": "products",
            "entity": "Why India’s GLP-1 boom could put fakes in your vials",
            "attribute": "references product",
            "value": "Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-3ml-cartridge"
        }
    ],
    "buy": [],
    "faq": [
        {
            "q": "What's the difference between GLP-1, dual, and triple agonist peptides?",
            "a": "GLP-1 single agonists (semaglutide) hit one receptor. Dual agonists (tirzepatide) hit GLP-1 and GIP. Triple agonists (retatrutide) add glucagon receptor activity on top of both."
        },
        {
            "q": "Does high market demand affect peptide purity for research use?",
            "a": "Yes. Fast-growing demand draws in more unverified manufacturers, so checking a certificate of analysis matters more, not less, when a compound is trending."
        },
        {
            "q": "How should reconstituted GLP-1 class peptides be stored?",
            "a": "Refrigerate at roughly 2 to 8°C, protect from light, and avoid repeated warm-up cycles, which degrade longer, multi-target peptides faster than simpler ones."
        }
    ],
    "jsonld": [
        {
            "@context": "https://schema.org",
            "@type": "Article",
            "headline": "Why India’s GLP-1 boom could put fakes in your vials",
            "url": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes",
            "mainEntityOfPage": "https://www.preppinpeppers.com/blogs/the-lab/why-india-s-glp-1-boom-could-put-fakes",
            "datePublished": "2026-09-14",
            "dateModified": "2026-10-16",
            "author": {
                "@type": "Person",
                "name": "PreppinPeppers Editorial Team"
            },
            "publisher": {
                "@type": "Organization",
                "name": "PreppinPeppers"
            },
            "description": "A surge in demand for GLP-1 research peptides from India is drawing unvetted manufacturers into the supply chain, raising the odds of a mislabeled or fake vial."
        },
        {
            "@context": "https://schema.org",
            "@type": "FAQPage",
            "url": "https://www.preppinpeppers.com/facts/why-india-s-glp-1-boom-could-put-fakes",
            "mainEntity": [
                {
                    "@type": "Question",
                    "name": "What's the difference between GLP-1, dual, and triple agonist peptides?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "GLP-1 single agonists (semaglutide) hit one receptor. Dual agonists (tirzepatide) hit GLP-1 and GIP. Triple agonists (retatrutide) add glucagon receptor activity on top of both."
                    }
                },
                {
                    "@type": "Question",
                    "name": "Does high market demand affect peptide purity for research use?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Yes. Fast-growing demand draws in more unverified manufacturers, so checking a certificate of analysis matters more, not less, when a compound is trending."
                    }
                },
                {
                    "@type": "Question",
                    "name": "How should reconstituted GLP-1 class peptides be stored?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Refrigerate at roughly 2 to 8°C, protect from light, and avoid repeated warm-up cycles, which degrade longer, multi-target peptides faster than simpler ones."
                    }
                }
            ]
        }
    ],
    "dates": {
        "published": "2026-09-14",
        "modified": "2026-10-16"
    }
}